NCT01849055View on ClinicalTrials.gov

A Multiple Dose Study of LY3023703 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Healthy Volunteers
Interventions
DRUG

Placebo

Administered orally

DRUG

LY3023703

Administered orally

DRUG

Celecoxib

Administered orally

Trial Locations (1)

47710

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Evansville

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01849055 - A Multiple Dose Study of LY3023703 in Healthy Participants | Biotech Hunter | Biotech Hunter